BDBM50067636 3-(3-{[3-(Benzo[1,3]dioxol-5-yloxy)-2-hydroxy-propyl]-methyl-amino}-propyl)-2-(3,5-di-tert-butyl-4-hydroxy-phenyl)-thiazolidin-4-one::CHEMBL137324
SMILES: CN(CCCN1C(SCC1=O)c1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C)CC(O)COc1ccc2OCOc2c1
InChI Key: InChIKey=VLRKCLYSNVDLNZ-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Calcium channel (RAT) | BDBM50067636 (3-(3-{[3-(Benzo[1,3]dioxol-5-yloxy)-2-hydroxy-prop...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | 430 | n/a | n/a | n/a | n/a | n/a | n/a |
Chugai Pharmaceutical Company, Ltd. Curated by ChEMBL | Assay Description In vitro inhibition of K+ induced contractions of the isolated rat aorta. | J Med Chem 41: 4309-16 (1998) Article DOI: 10.1021/jm980335f BindingDB Entry DOI: 10.7270/Q23N22JV | |||||||||||
More data for this Ligand-Target Pair |